SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma board to consider Final Dividend

21 May 2015 Evaluate

Anuh Pharma has informed that a meeting of the Board of Directors of the Company will be held on May 29, 2015, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2015; to recommend final Dividend, if any, for the financial year 2014-15; to consider the day, date and place of 55th Annual General Meeting of the Company; and to consider the Book-Closure dates. Further, as per the Code of Conduct for Prevention of Insider Trading of the Company, the trading window for dealing in the securities of the Company shall remain closed for all the Directors, Officers, Designated Employees and others covered under the said Code from May 21, 2015 till June 02, 2015.

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma Share Price

83.07 1.97 (2.43%)
21-Apr-2026 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1671.70
Dr. Reddys Lab 1225.70
Cipla 1232.80
Zydus Lifesciences 932.40
Lupin 2327.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×